Sotalol Hydrochloride Tablet
Product Images NDC 71610-723

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 71610-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 80 mg (71610 0723 30)

Bottle Label 80 mg (71610 0723 30)
Sotalol Hydrochloride 80 mg oral tablets packaging label displaying a bottle containing 30 tablets. The label includes the NDC number 71610-0723-30 and storage instructions to keep between 20-25 degrees Celsius, protect from light, and keep out of reach of children. The labeler is Aphena Pharma Solutions - Tennessee, LLC, located in Toronto, Canada.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure.jpg (Figure)

Figure.jpg (Figure)
A graph showing the relationship between Age Factor and Age in months. The X-axis represents age from 0.1 to 50 months on a logarithmic scale, and the Y-axis represents the Age Factor from 0.0 to 1.0. The curve increases rapidly at younger ages and gradually levels off, reaching an Age Factor of 1 for ages greater than 24 months.*
FDA Label Image

Figure2study1.jpg (Figure2study1)

Figure2study1.jpg (Figure2study1)
A Kaplan-Meier survival curve graph depicting recurrence-free survival over time in days for different oral sotalol dosages (80 mg, 120 mg, and 160 mg) compared to placebo. The graph includes p-values from a log-rank test for each dosage versus placebo, illustrating statistical comparison of survival rates.*
FDA Label Image

Figure3study2.jpg (Figure3study2)

Figure3study2.jpg (Figure3study2)
A Kaplan-Meier curve chart showing recurrence-free survival over time (days) comparing oral Sotalol Hydrochloride and placebo. The survival probability decreases over time for both groups, with the Sotalol Hydrochloride group demonstrating higher recurrence-free survival rates. A p-value of 0.002 (Log-Rank test) is noted, indicating statistical significance.*
FDA Label Image

Structur.jpg (Structurefigure)

Structur.jpg (Structurefigure)
Chemical structure of sotalol hydrochloride depicting its molecular components including sulfonamide, phenyl group, hydroxyl, amine, isopropyl groups, and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.